GENESIS: a French national resource to study the missing heritability of breast cancer.

Abstract:

BACKGROUND:Less than 20% of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE SISter) study was designed to identify new breast cancer susceptibility genes in women attending cancer genetics clinics and with no BRCA1/2 mutation. METHODS:The study involved the French national network of family cancer clinics. It was based on enrichment in genetic factors of the recruited population through case selection relying on familial criteria, but also on the consideration of environmental factors and endophenotypes like mammary density or tumor characteristics to assess potential genetic heterogeneity. One of the initial aims of GENESIS was to recruit affected sibpairs. Siblings were eligible when index cases and at least one affected sister were diagnosed with infiltrating mammary or ductal adenocarcinoma, with no BRCA1/2 mutation. In addition, unrelated controls and unaffected sisters were recruited. The enrolment of patients, their relatives and their controls, the collection of the clinical, epidemiological, familial and biological data were centralized by a coordinating center. RESULTS:Inclusion of participants started in February 2007 and ended in December 2013. A total of 1721 index cases, 826 affected sisters, 599 unaffected sisters and 1419 controls were included. 98% of participants completed the epidemiological questionnaire, 97% provided a blood sample, and 76% were able to provide mammograms. Index cases were on average 59 years old at inclusion, were born in 1950, and were 49.7 years of age at breast cancer diagnosis. The mean age at diagnosis of affected sisters was slightly higher (51.4 years). The representativeness of the control group was verified. CONCLUSIONS:The size of the study, the availability of biological specimens and the clinical data collection together with the detailed and complete epidemiological questionnaire make this a unique national resource for investigation of the missing heritability of breast cancer, by taking into account environmental and life style factors and stratifying data on endophenotypes to decrease genetic heterogeneity.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Sinilnikova OM,Dondon MG,Eon-Marchais S,Damiola F,Barjhoux L,Marcou M,Verny-Pierre C,Sornin V,Toulemonde L,Beauvallet J,Le Gal D,Mebirouk N,Belotti M,Caron O,Gauthier-Villars M,Coupier I,Buecher B,Lortholary A,Dugast

doi

10.1186/s12885-015-2028-9

subject

Has Abstract

pub_date

2016-01-12 00:00:00

pages

13

issn

1471-2407

pii

10.1186/s12885-015-2028-9

journal_volume

16

pub_type

杂志文章
  • Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study.

    abstract:BACKGROUND:The metabolic consequences of preoperative carbohydrate load in breast cancer patients are not known. The present explorative study investigated the systemic and tumor metabolic changes after preoperative per-oral carbohydrate load and their influence on tumor characteristics and survival. METHODS:The study...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-019-6393-7

    authors: Lende TH,Austdal M,Bathen TF,Varhaugvik AE,Skaland I,Gudlaugsson E,Egeland NG,Lunde S,Akslen LA,Jonsdottir K,Janssen EAM,Søiland H,Baak JPA

    更新日期:2019-12-04 00:00:00

  • The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.

    abstract:BACKGROUND:Mantle Cell Lymphoma (MCL) is often associated with progression, temporary response to therapy and a high relapse rate over time resulting in a poor long-term prognosis. Because MCL is classified as an incurable disease, therapeutic resistance is of great interest. However, knowledge about the biological mec...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-016-2844-6

    authors: Hanf M,Chiron D,de Visme S,Touzeau C,Maisonneuve H,Jardel H,Pellat-Deceunynck C,Amiot M,le Gouill S

    更新日期:2016-10-14 00:00:00

  • Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.

    abstract:BACKGROUND:Extrahepatic biliary duct cancers (EBDC) are uncommon malignancies characterized by a poor prognosis with high rate of loco-regional recurrence. The purpose of the present study is to assess the feasibility and the potential impact of adjuvant radiotherapy (RT) in a series of patients treated in one institut...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-267

    authors: Bonet Beltrán M,Roth AD,Mentha G,Allal AS

    更新日期:2011-06-24 00:00:00

  • Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.

    abstract:BACKGROUND:Oxidative stress is a widely seen phenomenon in several carcinomas. Increasing evidence also suggests that it has a significant role in the development of epithelial ovarian carcinoma (EOC). 8-Hydroxydeoxyguanosine (8-OHdG) is one of the main indicators of oxidative stress and increased expression of 8-OHdG ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1504-6

    authors: Pylväs-Eerola M,Karihtala P,Puistola U

    更新日期:2015-07-02 00:00:00

  • Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.

    abstract:BACKGROUND:Lymphangiogenesis has become a new research frontier in tumor metastasis since the discovery of reliable lymphatic markers that have allowed observation and isolation of lymphatic endothelium. Cyclooxygenase-2 (COX-2) has been reported to be involved in the critical steps in carcinogenesis. However, possible...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-4

    authors: Zhang XH,Huang DP,Guo GL,Chen GR,Zhang HX,Wan L,Chen SY

    更新日期:2008-01-13 00:00:00

  • Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.

    abstract:BACKGROUND:Amyloid-β precursor protein (APP) is a highly conserved single transmembrane protein that has been linked to Alzheimer disease. Recently, the increased expression of APP in multiple types of cancers has been reported where it has significant correlation with the cancer cell proliferation. However, the functi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-928

    authors: Lim S,Yoo BK,Kim HS,Gilmore HL,Lee Y,Lee HP,Kim SJ,Letterio J,Lee HG

    更新日期:2014-12-10 00:00:00

  • miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.

    abstract:BACKGROUND:Altered expression of microRNAs (miRNAs) is known to contribute to cancer progression. miR-23b and miR-27b, encoded within the same miRNA cluster, are reported to have both tumor suppressive and oncogenic activity across human cancers, including breast cancer. METHODS:To clarify this dichotomous role in bre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5839-2

    authors: Hannafon BN,Cai A,Calloway CL,Xu YF,Zhang R,Fung KM,Ding WQ

    更新日期:2019-06-28 00:00:00

  • Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.

    abstract:BACKGROUND:Neoadjuvant chemotherapy (NAC) is a standard treatment for stage II/III breast cancer patients, and response to NAC is a useful prognostic marker. Since its introduction, 6-8 cycles of NAC has become the standard regimen to improve the outcome of these patients. The purpose of this study is to evaluate the p...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2500-1

    authors: Yang Y,Im SA,Keam B,Lee KH,Kim TY,Suh KJ,Ryu HS,Moon HG,Han SW,Oh DY,Han W,Kim TY,Park IA,Noh DY

    更新日期:2016-07-21 00:00:00

  • Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib.

    abstract:BACKGROUND:New therapeutic principles in clinical oncology require the adjustment of response criteria to govern therapy decisions. For advanced hepatocellular carcinoma (HCC) a new era has recently begun by the approval of the multikinase inhibitor sorafenib. As a unique feature, HCC usually develops in a diseased liv...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-208

    authors: Horger M,Lauer UM,Schraml C,Berg CP,Koppenhöfer U,Claussen CD,Gregor M,Bitzer M

    更新日期:2009-06-28 00:00:00

  • Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients.

    abstract:BACKGROUND:From 2008, Danish general practitioners could refer patients suspected of having cancer to standardised cancer patient pathways (CPPs). We aimed to compare the length of the diagnostic interval in 2010 with the length of the diagnostic interval before (2004/05) and during (2007/08) the implementation of CPPs...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1317-7

    authors: Jensen H,Tørring ML,Olesen F,Overgaard J,Fenger-Grøn M,Vedsted P

    更新日期:2015-04-23 00:00:00

  • Cyr61 expression is associated with prognosis in patients with colorectal cancer.

    abstract:BACKGROUND:Cysteine-rich 61 (Cyr61), a member of the CCN protein family, possesses diverse functionality in cellular processes such as adhesion, migration, proliferation, and survival. Cyr61 can also function as an oncogene or a tumour suppressor, depending on the origin of the cancer. Only a few studies have reported ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-164

    authors: Jeong D,Heo S,Sung Ahn T,Lee S,Park S,Kim H,Park D,Byung Bae S,Lee SS,Soo Lee M,Kim CJ,Jun Baek M

    更新日期:2014-03-07 00:00:00

  • Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.

    abstract:BACKGROUND:Patients with metastatic renal carcinoma frequently have pre-existing renal impairment and not infrequently develop worsening renal function as a complication of their treatment. The presence of pancreatic metastases in patients with metastatic renal carcinoma, often confers a more favourable prognosis and a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6215-y

    authors: Purshouse K,Chamberlain S,Soares M,Tuthill M,Protheroe A,Mole DR

    更新日期:2019-10-17 00:00:00

  • An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.

    abstract:BACKGROUND:The radiopharmaceutical (131)I-meta-iodobenzylguanidine ((131)I-MIBG) is an effective treatment for neuroblastoma. However, maximal therapeutic benefit from (131)I-MIBG is likely to be obtained by its combination with chemotherapy. We previously reported enhanced antitumour efficacy of (131)I-MIBG by inhibit...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2656-8

    authors: Nile DL,Rae C,Hyndman IJ,Gaze MN,Mairs RJ

    更新日期:2016-08-11 00:00:00

  • BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors.

    abstract:BACKGROUND:The prognosis for patients with recurrent glioblastoma is still poor with a median survival between 3 and 6 months. Reports about the application of carmustine (BCNU), one of the standard chemotherapeutic drugs in the treatment of newly diagnosed glioblastoma, in the recurrent situation are rare. METHODS:We...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-30

    authors: Reithmeier T,Graf E,Piroth T,Trippel M,Pinsker MO,Nikkhah G

    更新日期:2010-02-02 00:00:00

  • Active smoking and risk of breast cancer in a Danish nurse cohort study.

    abstract:BACKGROUND:No scientific consensus has been reached on whether active tobacco smoking causes breast cancer. We examine the association between active smoking and breast cancer risk in Denmark, which has some of the highest smoking and breast cancer rates in women worldwide. METHODS:We used the data from a nationwide D...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3546-4

    authors: Andersen ZJ,Jørgensen JT,Grøn R,Brauner EV,Lynge E

    更新日期:2017-08-22 00:00:00

  • Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy.

    abstract:BACKGROUND:The purpose of this study was to identify the risk factors associated with fatal pulmonary hemorrhage (PH) in patients with locally advanced non-small cell lung cancer (NSCLC), treated with chemoradiotherapy. METHODS:The medical records of 583 patients with locally advanced NSCLC, who were treated with chem...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-27

    authors: Ito M,Niho S,Nihei K,Yoh K,Ohmatsu H,Ohe Y

    更新日期:2012-01-20 00:00:00

  • Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

    abstract:BACKGROUND:Toll-like receptors (TLRs) have garnered an extraordinary amount of interest in cancer research due to their role in tumor progression. By activating the production of several biological factors, TLRs induce type I interferons and other cytokines, which drive an inflammatory response and activate the adaptiv...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-665

    authors: González-Reyes S,Marín L,González L,González LO,del Casar JM,Lamelas ML,González-Quintana JM,Vizoso FJ

    更新日期:2010-12-03 00:00:00

  • EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.

    abstract:BACKGROUND:Non-small cell lung cancer (NSCLC) is one of the most aggressive types of cancer. However, resistance to cisplatin (CDDP) remains a major challenge in NSCLC treatment. The purpose of this study was to investigate the ability of EHD1 [Eps15 homology (EH) domain - containing protein 1] to confer CDDP resistanc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2527-3

    authors: Gao J,Meng Q,Zhao Y,Chen X,Cai L

    更新日期:2016-07-13 00:00:00

  • Correction to: A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.

    abstract::An amendment to this paper has been published and can be accessed via the original article. ...

    journal_title:BMC cancer

    pub_type: 已发布勘误

    doi:10.1186/s12885-020-07245-x

    authors: Al-Khayal K,Vaali-Mohammed MA,Elwatidy M,Traiki TB,Al-Obeed O,Azam M,Khan Z,Abdulla M,Ahmad R

    更新日期:2020-09-01 00:00:00

  • Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.

    abstract:BACKGROUND:Expression of Nodal, a member of the TGF-β superfamily, is commonly absent in differentiated tissues, while its re-expression occurs in a variety of human malignancy. However, little is known about its involvement in ovarian tumorigenesis. Herein, we focused on the functional roles of Nodal in ovarian endome...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5539-y

    authors: Miura R,Yokoi A,Matsumoto T,Oguri Y,Hashimura M,Tochimoto M,Kajita S,Saegusa M

    更新日期:2019-04-03 00:00:00

  • Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study.

    abstract:BACKGROUND:Utilisation of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and guide sheath (EBUS-GS) for diagnosis and staging of lung cancer is gaining popularity, however, its impact on clinical practice is unclear. This study aimed to determine the impact of the introduction of endobronc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2081-z

    authors: Slavova-Azmanova NS,Lizama C,Johnson CE,Ludewick HP,Lester L,Karunarathne S,Phillips M

    更新日期:2016-01-28 00:00:00

  • A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.

    abstract:BACKGROUND:Lung adenocarcinoma (LUAD) is a major cause of cancer death. Therefore, identifying potential prognostic risk factors is critical to improve the survival of patients with LUAD. METHODS:Here, relevant datasets were downloaded from TCGA and GEO databases to screen the differentially expressed genes (DEGs). Un...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07235-z

    authors: Jiang H,Xu S,Chen C

    更新日期:2020-08-20 00:00:00

  • CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.

    abstract:BACKGROUND:In past decades, circular RNAs (circRNAs) have achieved increasing attention because of its regulatory role in different kinds of cancers. However, how circAGFG1 regulates cervical cancer (CC) is still largely undiscovered. This study aims to evaluate the role of a novel circRNAs and related molecular mechan...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6269-x

    authors: Wu F,Zhou J

    更新日期:2019-11-08 00:00:00

  • Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.

    abstract:BACKGROUND:This study aimed to determine the efficacy and complications of intravitreal chemotherapy-assisted endoresection for refractory International Classification of Retinoblastoma (ICRB) group D retinoblastoma in monocular patients. METHODS:In this retrospective case series, intravitreal chemotherapy-assisted en...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07314-1

    authors: Yu X,Li X,Xing Y,Lu S,Tanumiharjo S,Ma J

    更新日期:2020-08-26 00:00:00

  • Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016).

    abstract:BACKGROUND:We examined 15 years of key performance indicators (KPIs) of the population-based mammography screening programme (PMSP) in Flanders, Belgium. METHODS:Individual screening data were linked to the national cancer registry to obtain oncological follow-up. We benchmarked crude KPI results against KPI-targets s...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6230-z

    authors: Goossens M,De Brabander I,De Grève J,Van Ongeval C,Martens P,Van Limbergen E,Kellen E

    更新日期:2019-10-28 00:00:00

  • Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.

    abstract:BACKGROUND:The phenomenon that malignant cells can acquire stemness under specific stimuli, encompassed under the concept of cancer cell plasticity, has been well-described in epithelial malignancies. To our knowledge, cancer cell plasticity has not yet been described in hematopoietic cancers. To illustrate and study c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4300-2

    authors: Wu C,Gupta N,Huang YH,Zhang HF,Alshareef A,Chow A,Lai R

    更新日期:2018-04-02 00:00:00

  • EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.

    abstract:BACKGROUND:The EGFR and downstream signaling pathways play an important role in tumorigenesis in oral squamous cell carcinoma (OSCC). Gene copy number alteration is one mechanism for overexpressing the EGFR protein and was also demonstrated to be related to lymph node metastasis, tumor invasiveness and perineural invas...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3586-9

    authors: Huang SF,Chien HT,Cheng SD,Chuang WY,Liao CT,Wang HM

    更新日期:2017-08-30 00:00:00

  • Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report.

    abstract:BACKGROUND:To the best of our knowledge, no study has reported mediastinal shift accompanied with obstructive atelectasis due to bulky primary esophageal tumor components treated with adaptive radiotherapy and concurrent chemotherapy. CASE PRESENTATION:Here we report the case of a 65-year-old male patient diagnosed wi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6505-4

    authors: Sakanaka K,Fujii K,Mizowaki T

    更新日期:2020-01-06 00:00:00

  • Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up.

    abstract:BACKGROUND:Racial disparities are well-documented in preventive cancer care, but they have not been fully explored in the context of lung cancer screening. We sought to explore racial differences in lung cancer screening outcomes within a lung cancer screening program (LCSP) at our urban academic medical center includi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06923-0

    authors: Lake M,Shusted CS,Juon HS,McIntire RK,Zeigler-Johnson C,Evans NR,Kane GC,Barta JA

    更新日期:2020-06-16 00:00:00

  • Return to work in sick-listed cancer survivors with job loss: design of a randomised controlled trial.

    abstract:BACKGROUND:Despite long-term or permanent health problems, cancer survivors are often motivated to return to work. For cancer survivors who have lost their job, return to work can be more challenging compared to employed survivors, as they generally find themselves in a more vulnerable social and financial position. Ca...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-015-1051-1

    authors: van Egmond MP,Duijts SF,Vermeulen SJ,van der Beek AJ,Anema JR

    更新日期:2015-02-18 00:00:00